Health Jul 26 FDA will consider approval of biosimilar drug for first time Americans are a small step closer to accessing less-expensive specialty drugs known as biologics. The Food and Drug Administration for the first time accepted an application for the approval of a copycat “generic” version of the brand name drug Neupogen,… By Hannah Yi